1 Result: Benign Prostatic Hyperplasia
Breaking: FDA Greenlights Profound Medical's TULSA AI Module
September 26th, 2023
Shares of Profound Medical Corp. (Nasdaq: PROF) surged by more than 10% in after-hours trading after it announced FDA clearance for its Thermal Boost module in conjunction with TULSA-PRO, which allows surgeons to treat various prostate conditions, in. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024Financial Focus: MongoDB, Samsara, and Guidewire Earnings Ahead
March 03rd, 2024
Member Login